COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
CollPlant Biotechnologies (NASDAQ: CLGN) has announced it will release its third quarter 2024 financial results on Wednesday, November 27, 2024, before U.S. markets open. The company will host a conference call and webcast at 10:00 a.m. EST on the same day to discuss the results and provide corporate updates. Investors can participate via phone or through a live webcast available on the company's investor relations website. Questions for management can be submitted in advance via email.
CollPlant Biotechnologies (NASDAQ: CLGN) ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 mercoledì 27 novembre 2024, prima dell'apertura dei mercati statunitensi. L'azienda terrà una conference call e un webcast alle 10:00 a.m. EST lo stesso giorno per discutere i risultati e fornire aggiornamenti aziendali. Gli investitori possono partecipare telefonicamente o tramite un webcast in diretta disponibile sul sito web delle relazioni con gli investitori dell'azienda. Le domande per la direzione possono essere inviate in anticipo via email.
CollPlant Biotechnologies (NASDAQ: CLGN) ha anunciado que publicará sus resultados financieros del tercer trimestre de 2024 el miércoles 27 de noviembre de 2024, antes de la apertura del mercado estadounidense. La compañía realizará una conferencia telefónica y un webcast a las 10:00 a.m. EST el mismo día para discutir los resultados y proporcionar actualizaciones corporativas. Los inversores pueden participar por teléfono o a través de un webcast en vivo disponible en el sitio web de relaciones con los inversores de la empresa. Las preguntas para la dirección pueden enviarse con anticipación por correo electrónico.
CollPlant Biotechnologies (NASDAQ: CLGN)는 2024년 11월 27일 수요일에 2024년 3분기 재무 결과를 발표할 것이라고 발표했습니다. 발표는 미국 시장이 열리기 전에 이루어집니다. 회사는 같은 날 오전 10시 EST에 결과를 논의하고 기업 업데이트를 제공하기 위해 컨퍼런스 콜과 웹캐스트를 개최할 것입니다. 투자자들은 전화를 통해 또는 회사의 투자자 관계 웹사이트에서 제공하는 실시간 웹캐스트를 통해 참여할 수 있습니다. 경영진에 대한 질문은 사전에 이메일로 제출할 수 있습니다.
CollPlant Biotechnologies (NASDAQ: CLGN) a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 le mercredi 27 novembre 2024, avant l'ouverture des marchés américains. L'entreprise tiendra une conférence téléphonique et un webinaire à 10h00 EST le même jour pour discuter des résultats et fournir des mises à jour sur l'entreprise. Les investisseurs peuvent participer par téléphone ou via un webinaire en direct disponible sur le site de relations avec les investisseurs de la société. Les questions pour la direction peuvent être soumises à l'avance par e-mail.
CollPlant Biotechnologies (NASDAQ: CLGN) hat angekündigt, dass es am Mittwoch, den 27. November 2024, vor der Eröffnung der US-Märkte seine Finanzergebnisse für das dritte Quartal 2024 veröffentlichen wird. Das Unternehmen wird am selben Tag um 10:00 Uhr EST eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse zu besprechen und Unternehmensupdates bereitzustellen. Investoren können telefonisch oder über einen Live-Webcast teilnehmen, der auf der Website der Investor Relations des Unternehmens verfügbar ist. Fragen an das Management können im Voraus per E-Mail eingereicht werden.
- None.
- None.
- Conference call to be held on Wednesday, November 27, 2024 at 10:00 a.m.
REHOVOT,
Conference call information
To participate in the conference call, please use the dial-in information below:
Investors outside of the U.S.: 1-201-493-6779
Conference ID: 13749096
Note, you can avoid long wait times for the operator by using the Call me™ feature and clicking the link below 15 minutes prior to the scheduled call start time:
https://callme.viavid.com/viavid/?callme=true&passcode=13728588&h=true&info=company-email&r=true&B=6
Webcast information
A live webcast will also be available in listen-only mode and can be accessed here or via the link to be posted on the News & Events section of the CollPlant Investor relations website. A replay of the webcast will be available following the conclusion of the live broadcast and will be accessible on the Company's website for a limited time.
Submit questions to management in advance of the call
To ask management a question ahead of the call, please email Dan Ferry at LifeSci Advisors LLC up until 24 hours before the event at daniel@lifesciadvisors.com.
About CollPlant
CollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics. The Company's products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant-based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing, and are ushering in a new era in regenerative and aesthetic medicine.
In 2021, CollPlant entered into a development and global commercialization agreement for dermal and soft tissue fillers with Allergan, an AbbVie company, the global leader in the dermal filler market.
For more information about CollPlant, visit http://www.collplant.com
Contacts
CollPlant:
Eran Rotem
Deputy CEO & CFO
Tel: + 972-73-2325600
Email: Eran@collplant.com
Investors:
LifeSci Advisors
Dan Ferry
daniel@lifesciadvisors.com
Logo - https://mma.prnewswire.com/media/2217353/CollPlant_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/collplant-biotechnologies-announces-date-for-2024-third-quarter-financial-results-and-conference-call-information-302302386.html
SOURCE CollPlant
FAQ
When will CollPlant Biotechnologies (CLGN) release Q3 2024 earnings?
What time is CollPlant's (CLGN) Q3 2024 earnings call?
How can investors join CollPlant's (CLGN) Q3 2024 earnings call?
